secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001193125-26-031942
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.03, 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla adopts 1-for-50 reverse stock split via merger after Nasdaq policy reversal; delisting risk
--------------------------------------------------------------------------------

- Issued one share of super-voting Series A Preferred to pass reverse split (100M votes for), then redeemed it for $0.01.
- Board chose not to implement reverse split; Nasdaq said super-voting use now violates Rule 5640 without public notice.
- Entered merger for 1-for-50 reverse split; requires majority stockholder vote at special meeting.
- AIRC confirmed investment in Inversagen AI; BioAtla to receive $5M for 4.375% of SPV common units.
- Nasdaq compliance deadline Feb 2; company believes Nasdaq's delays and policy change were in error and harmful.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526031942/0001193125-26-031942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526031942/bcab-20260126.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-031942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer